Elevated circulating levels of CCL2, CCL3, CCL4, and CCL5 have been reported in patients with osteoporosis, suggesting that excessive chemokine signaling may enhance osteoclast recruitment and inflammatory bone resorption. The gene discussed is CCL4; the disease is osteoporosis.